Literature DB >> 12915130

Immortalisation of human ovarian surface epithelium with telomerase and temperature-sensitive SV40 large T antigen.

Barry R Davies1, Islay A Steele, Richard J Edmondson, Simon A Zwolinski, Gabriele Saretzki, Thomas von Zglinicki, Michael J O'Hare.   

Abstract

Epithelial ovarian cancer is the most common form of gynaecological malignancy. This lethal disease is thought to arise in ovarian surface epithelial (OSE) cells. The biology of these cells is not well understood, due to the limited amount of tissue that can be obtained from a single biopsy and their limited life span in culture. To overcome these problems, we have conditionally immortalised OSE cells with the catalytic subunit of telomerase (hTERT) and a temperature-sensitive form of SV40 Large T antigen (tsT). We have maintained these cells (designated OSE-C2) in culture for more than 100 population doublings after introduction of the immortalising genes. Early passage OSE-C2 cells have a near-tetraploid karyotype and exhibit a dual mesenchymal-epithelial phenotype, with consistent expression of vimentin and variable expression of cytokeratins and type III collagen, and absence of E cadherin expression. OSE-C2 cells proliferate steadily at the permissive temperature of 33 degrees C, but fail to increase in number at the nonpermissive temperature of 39 degrees C. Serum-deprived OSE-C2 cells are stimulated to grow at 33 degrees C by EGF, whereas they are growth inhibited at 33 degrees C by TGFbeta in the presence or the absence of serum. When temperature shifted to the nonpermissive temperature, OSE-C2 cells modulate to a more mesenchymal phenotype, and a proportion of the cells undergo senescence and/or apoptosis. Moreover, at the nonpermissive temperature, the levels of p53 and SV40 Large T antigen diminish, whilst the level of p21 increases, whereas the level of p16 and telomerase activity is unchanged. This experimental system shows that expression of telomerase alone only allows limited proliferative potential of OSE cells; expression of tsT is necessary to maintain these cells in culture for longer periods, perhaps by its ability to inactivate components of the p53/Rb pathway. OSE-C2 cells may be useful in studying the physiology and differentiation of human OSE cells and provide insight into the poorly understood earliest stages of epithelial ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12915130     DOI: 10.1016/s0014-4827(03)00218-0

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  24 in total

Review 1.  The mammalian ovary from genesis to revelation.

Authors:  Mark A Edson; Ankur K Nagaraja; Martin M Matzuk
Journal:  Endocr Rev       Date:  2009-09-23       Impact factor: 19.871

2.  Targeting Nrf2 in healthy and malignant ovarian epithelial cells: Protection versus promotion.

Authors:  Monique G P van der Wijst; Christian Huisman; Archibold Mposhi; Gerard Roelfes; Marianne G Rots
Journal:  Mol Oncol       Date:  2015-03-19       Impact factor: 6.603

3.  Immortalized functional endothelial progenitor cell lines from umbilical cord blood for vascular tissue engineering.

Authors:  Praveen K Sobhan; Mahendra Seervi; Jeena Joseph; Saneesh Varghese; Prakash Rajappan Pillai; Divya Mundackal Sivaraman; Jackson James; Roshin Elizabeth George; K E Elizabeth; T R Santhoshkumar; M Radhakrishna Pillai
Journal:  Tissue Eng Part C Methods       Date:  2012-10-01       Impact factor: 3.056

4.  Immortalization of Human Fetal Hepatocyte by Ectopic Expression of Human Telomerase Reverse Transcriptase, Human Papilloma Virus (E7) and Simian Virus 40 Large T (SV40 T) Antigen Towards Bioartificial Liver Support.

Authors:  Shibashish Giri; Augustinus Bader
Journal:  J Clin Exp Hepatol       Date:  2014-09-18

5.  Ovarian Cancers Harbor Defects in Nonhomologous End Joining Resulting in Resistance to Rucaparib.

Authors:  Aiste McCormick; Peter Donoghue; Michelle Dixon; Richard O'Sullivan; Rachel L O'Donnell; James Murray; Angelika Kaufmann; Nicola J Curtin; Richard J Edmondson
Journal:  Clin Cancer Res       Date:  2016-10-04       Impact factor: 12.531

6.  Characterization of immortalized mesenchymal stem cells derived from foetal porcine pancreas.

Authors:  H Cao; Y Chu; H Zhu; J Sun; Y Pu; Z Gao; C Yang; S Peng; Z Dou; J Hua
Journal:  Cell Prolif       Date:  2011-02       Impact factor: 6.831

7.  Immortalization of human umbilical vein endothelial cells with telomerase reverse transcriptase and simian virus 40 large T antigen.

Authors:  Chang Bian; Kui Zhao; Guo-xin Tong; Yong-liang Zhu; Peng Chen
Journal:  J Zhejiang Univ Sci B       Date:  2005-07       Impact factor: 3.066

8.  Immortalization of human precartilaginous stem cells by transfecting SV40Tag.

Authors:  Junfang Wang; Huang Fang; Renyun Xia; Anming Chen; Hao Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2009-04-28

9.  Androgen-related expression of G-proteins in ovarian cancer.

Authors:  L A Sheach; E M Adeney; A Kucukmetin; S J Wilkinson; A D Fisher; A Elattar; C N Robson; R J Edmondson
Journal:  Br J Cancer       Date:  2009-07-21       Impact factor: 7.640

10.  The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer.

Authors:  Arthur B McKie; Sebastian Vaughan; Elisa Zanini; Imoh S Okon; Louay Louis; Camila de Sousa; Mark I Greene; Qiang Wang; Roshan Agarwal; Dmitry Shaposhnikov; Joshua L C Wong; Hatice Gungor; Szymon Janczar; Mona El-Bahrawy; Eric W-F Lam; Naomi E Chayen; Hani Gabra
Journal:  Cancer Discov       Date:  2012-02       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.